All posts by: Michael Zand

About Michael Zand

Shire’s haemophilia A gene therapy wins Orphan status – PharmaTimes

Continue reading

2017-10-26 NEWS

PharmaTimes

Shire’s haemophilia A gene therapy wins Orphan status
PharmaTimes
Shire’s gene therapy candidate SHP654, an investigational factor VIII gene therapy for the treatment of haemophilia A, has been awarded Orphan Drug Designation by US regulators. The move qualifies Shire for access to various incentives designed to …

Continue reading

2017-10-26 NEWS

WHAS 11.com

University. of Louisville researcher to lead stem cell summit
WHAS 11.com
LOUISVILLE, Ky. (AP) – A University of Louisville researcher will lead a summit on stem cell science at the annual meeting of the American Heart Association next month. Dr. Roberto Bolli is chief of the university’s division of Cardiovascular Medicine

and more »